Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 338 | $23.53 | $7,953.14 |
DisclosureSEC source: 0000078003-07-000207 · kin1563.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,290 Underlying: Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 910 | $23.53 | $21,412.30 |
DisclosureSEC source: 0000078003-07-000208 · lam1564.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,018 Underlying: Common Stock · 910 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 1,139 | $23.53 | $26,800.67 |
DisclosureSEC source: 0000078003-07-000209 · lev1565.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,247 Underlying: Common Stock · 1,139 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 573 | $23.53 | $13,482.69 |
DisclosureSEC source: 0000078003-07-000210 · rea1566.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,019 Underlying: Common Stock · 573 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 1,477 | $23.53 | $34,753.81 |
DisclosureSEC source: 0000078003-07-000211 · she1567.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,585 Underlying: Common Stock · 1,477 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 15, 2007 Filed Aug 17, 2007 12:54 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 106 | $23.53 | $2,494.18 |
DisclosureSEC source: 0000078003-07-000212 · wax1568.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,469 Underlying: Common Stock · 106 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 41 | $23.51 | $963.91 |
DisclosureSEC source: 0000078003-07-000182 · bag1551.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,454 Underlying: Common Stock · 41 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 46 | $23.51 | $1,081.46 |
DisclosureSEC source: 0000078003-07-000183 · can1552.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,033 Underlying: Common Stock · 46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 61 | $23.51 | $1,434.11 |
DisclosureSEC source: 0000078003-07-000184 · fec1553.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,570 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 116 | $23.51 | $2,727.16 |
DisclosureSEC source: 0000078003-07-000185 · kin1554.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,952 Underlying: Common Stock · 116 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 239 | $23.51 | $5,618.89 |
DisclosureSEC source: 0000078003-07-000186 · lam1555.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,108 Underlying: Common Stock · 239 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 365 | $23.51 | $8,581.15 |
DisclosureSEC source: 0000078003-07-000187 · lev1556.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,108 Underlying: Common Stock · 365 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 172 | $23.51 | $4,043.72 |
DisclosureSEC source: 0000078003-07-000188 · rea1557.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,446 Underlying: Common Stock · 172 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 371 | $23.51 | $8,722.21 |
DisclosureSEC source: 0000078003-07-000189 · she1558.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,108 Underlying: Common Stock · 371 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 31, 2007 Filed Aug 1, 2007 21:20 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 54 | $23.51 | $1,269.54 |
DisclosureSEC source: 0000078003-07-000190 · wax1559.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,363 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:46 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 37 | $25.91 | $958.67 |
DisclosureSEC source: 0000078003-07-000171 · bag1542.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,413 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:46 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 43 | $25.91 | $1,114.13 |
DisclosureSEC source: 0000078003-07-000172 · can1543.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,987 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:46 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 55 | $25.91 | $1,425.05 |
DisclosureSEC source: 0000078003-07-000173 · fec1544.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,509 Underlying: Common Stock · 55 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 107 | $25.91 | $2,772.37 |
DisclosureSEC source: 0000078003-07-000174 · kin1545.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 215 | $25.91 | $5,570.65 |
DisclosureSEC source: 0000078003-07-000175 · lam1546.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,869 Underlying: Common Stock · 215 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 327 | $25.91 | $8,472.57 |
DisclosureSEC source: 0000078003-07-000176 · lev1547.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,743 Underlying: Common Stock · 327 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 155 | $25.91 | $4,016.05 |
DisclosureSEC source: 0000078003-07-000177 · rea1548.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,274 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 336 | $25.91 | $8,705.76 |
DisclosureSEC source: 0000078003-07-000178 · she1549.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,737 Underlying: Common Stock · 336 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 13, 2007 Filed Jul 17, 2007 14:47 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 48 | $25.91 | $1,243.68 |
DisclosureSEC source: 0000078003-07-000179 · wax1550.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,309 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:44 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 1,202 | $25.57 | $30,735.14 |
DisclosureSEC source: 0000078003-07-000158 · cor1539.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,004 Underlying: Common Stock · 1,202 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:44 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 1,703 | $25.57 | $43,545.71 |
DisclosureSEC source: 0000078003-07-000159 · mea1540.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,500 Underlying: Common Stock · 1,703 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:44 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,175 | $25.57 | $30,044.75 |
DisclosureSEC source: 0000078003-07-000160 · ste1541.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,331 Underlying: Common Stock · 1,175 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 38 | $25.57 | $971.66 |
DisclosureSEC source: 0000078003-07-000161 · bag1530.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,376 Underlying: Common Stock · 38 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 43 | $25.57 | $1,099.51 |
DisclosureSEC source: 0000078003-07-000162 · can1531.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,944 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 56 | $25.57 | $1,431.92 |
DisclosureSEC source: 0000078003-07-000163 · fec1532.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,454 Underlying: Common Stock · 56 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 109 | $25.57 | $2,787.13 |
DisclosureSEC source: 0000078003-07-000164 · kin1533.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,729 Underlying: Common Stock · 109 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 217 | $25.57 | $5,548.69 |
DisclosureSEC source: 0000078003-07-000165 · lam1534.xml · derivative · entry 4 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,654 Underlying: Common Stock · 217 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
LAMATTINA JOHN LSenior Vice President
|
Tax withholdingCommon Stock | 6,264 | $25.57 | $160,170.48 |
DisclosureSEC source: 0000078003-07-000165 · lam1534.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,190 Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 330 | $25.57 | $8,438.10 |
DisclosureSEC source: 0000078003-07-000166 · lev1535.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,416 Underlying: Common Stock · 330 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 157 | $25.57 | $4,014.49 |
DisclosureSEC source: 0000078003-07-000167 · rea1536.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,119 Underlying: Common Stock · 157 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 339 | $25.57 | $8,668.23 |
DisclosureSEC source: 0000078003-07-000168 · she1537.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,401 Underlying: Common Stock · 339 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 29, 2007 Filed Jul 3, 2007 14:45 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 50 | $25.57 | $1,278.50 |
DisclosureSEC source: 0000078003-07-000169 · wax1538.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,261 Underlying: Common Stock · 50 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 36 | $26.47 | $952.92 |
DisclosureSEC source: 0000078003-07-000134 · bag1522.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,338 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 42 | $26.47 | $1,111.74 |
DisclosureSEC source: 0000078003-07-000135 · can1523.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,901 Underlying: Common Stock · 42 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 54 | $26.47 | $1,429.38 |
DisclosureSEC source: 0000078003-07-000136 · fec1524.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,398 Underlying: Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 104 | $26.47 | $2,752.88 |
DisclosureSEC source: 0000078003-07-000137 · kin1525.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,620 Underlying: Common Stock · 104 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 212 | $26.47 | $5,611.64 |
DisclosureSEC source: 0000078003-07-000138 · lam1521.xml · derivative · entry 5 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,437 Underlying: Common Stock · 212 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
LAMATTINA JOHN LSenior Vice President
|
GiftCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000138 · lam1521.xml · nonDerivative · entry 2 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,454 Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
LAMATTINA JOHN LSenior Vice President
|
SaleCommon Stock | 36,066 | $26.48 | $955,027.68 |
DisclosureSEC source: 0000078003-07-000138 · lam1521.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,454 Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 323 | $26.47 | $8,549.81 |
DisclosureSEC source: 0000078003-07-000139 · lev1526.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,086 Underlying: Common Stock · 323 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 152 | $26.47 | $4,023.44 |
DisclosureSEC source: 0000078003-07-000140 · rea1527.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,962 Underlying: Common Stock · 152 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 330 | $26.47 | $8,735.10 |
DisclosureSEC source: 0000078003-07-000141 · she1528.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,062 Underlying: Common Stock · 330 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2007 Filed Jun 18, 2007 20:38 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 47 | $26.47 | $1,244.09 |
DisclosureSEC source: 0000078003-07-000142 · wax1529.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,211 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 05, 2007 Filed Jun 6, 2007 19:00 UTC |
SHEDLARZ DAVID LVice Chairman
|
SaleCommon Stock | 6,349 | $27.15 | $172,375.35 |
DisclosureSEC source: 0000078003-07-000132 · she1520.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,310 Read SEC document |
| June 05, 2007 Filed Jun 6, 2007 19:00 UTC |
SHEDLARZ DAVID LVice Chairman
|
SaleCommon Stock | 25,000 | $27.16 | $679,000.00 |
DisclosureSEC source: 0000078003-07-000132 · she1520.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,659 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.